Comparison of taurine, GABA, Glu, and Asp as scavengers of malondialdehyde in vitro and in vivo

Nanoscale Research Letters

Volumn 8, Issue 1, 2013, Pages 1-9

  Deng, Yan ^a,b   Wang, Wei ^a   Yu, Pingfeng ^c   Xi, Zhijiang ^b   Xu, Lijian ^a   Li, Xiaolong ^a   He, Nongyue ^a,b  

^a HUNAN UNIVERSITY OF TECHNOLOGY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c Guangzhou The Bond Chemicals Co Ltd   (China)

Author keywords

Aspartate; Gamma aminobutyric acid; Glutamate; Malondialdehyde; Scavengers; Taurine

Indexed keywords

ALDEHYDES; ENZYMES; FREE RADICALS; PLANTS (BOTANY);

ASPARTATES; GAMMA-AMINOBUTYRIC ACIDS; GLUTAMATE; MALONDIALDEHYDE; SCAVENGERS; TAURINE;

AMINO ACIDS;

RATTUS;

EID: 84878754094     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-8-190     Document Type: Article

References (45)

1. Aldini G, Dalle-Donne I, Facino RM, Milzani A, Carini M: Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med Res Rev 2007, 27:817-868.
2. Baillet A, Chanteperdrix V, Trocmé C, Casez P, Garrel C, Besson G: The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease. Neurochem Res 2010, 35:1530-1537.
3. Costello DJ, Delanty N: Oxidation injury in epilepsy: potential for antioxidant therapy? Expert Rev Neurother 2004, 4:541-553.
4. Gabbita SP, Lovell MA, Markesbery WR: Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem 1998, 71:2034-2040.
5. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Siedlak SL, Tabaton M, Perry G: Amyloid-b deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 1998, 70:2212-2215.
6. Gironi M, Bianchi A, Russo A, Alberoni M, Ceresa L, Angelini A, Cursano C, Mariani E, Nemni R, Kullmann C, Farina E: Martinelli Boneschi F: Oxidative imbalance in different neurodegenerative diseases with memory impairment. Neurodegener Dis 2011, 8:129-137.
7. Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4- hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol Med 1991, 11:81-128.
8. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A: Protein carbonylation in human diseases. Trends Mol Med 2003, 9:169-176.
9. Slatter DA, Murray M, Bailey AJ: Formation of a dihydropyridine derivative as a potential cross-link derived from malondialdehyde in physiological systems. FEBS Lett 1998, 421:180-184.
10. Casado A, Encarnación López-Fernández M, Concepción Casado M, de La Torre R: Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 2008, 33:450-458.
11. Tomic S, Brkic S, Maric D, Mikic AN: Lipid and protein oxidation in female patients with chronic fatigue syndrome. Arch Med Sci 2012, 8(5):886-891.
12. Miyata T, Ueda Y, Saito A, Kurokawa K: Carbonyl stress and dialysis-related amyloidosis. Nephrol Dial Transplant 2000, 15:25-28.
13. Yin D: Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radical Biol Med 1996, 21:871-888.
14. Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Baynes JW: Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J 1997, 322:317-325.
15. Bonnes-Taourel D, Guérin MC, Torreilles J: Is malonaldehyde a valuable indicator of lipid peroxidation. Biochem Pharmacol 1992, 44:985-988.
16. Andersen JK: Oxidative stress in neurodegeneration: cause or consequence? Nat Rev Neurosci 2004, 5:S18-S25.
17. Browne SE, Ferrante RJ, Beal MF: Oxidative stress in Huntington's disease. Brain Pathol 1999, 9:147-163.
18. Hall ED, Andrus PK, Oostveen JA, Fleck TJ, Gurney ME: Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res 1998, 53:66-77.
19. Gustaw-Rothenberg K, Kowalczuk K, Stryjecka-Zimmer M: Lipids peroxidation markers in Alzheimer's disease and vascular dementia. Geriatr Gerontol Int 2010, 10:161-166.
20. Greilberger J, Koidl C, Greilberger M, Lamprecht M, Schroecksnadel K, Leblhuber F, Fuchs D, Oettl K: Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease. Free Radic Res 2008, 42:633-638.
21. Medina-Hernández V, Ramos-Loyo J, Luquin S, Sánchez LF, García-Estrada J, Navarro-Ruiz A: Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics. J Psychiatr Res 2007, 41:652-658.
22. Keller JN, Mattson MP: Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 1998, 9:105-116.
23. Tabassum H, Parvez S, Rehman H, Banerjee BD, Raisuddin S: Catechin as an antioxidant in liver mitochondrial toxicity: inhibition of tamoxifeninduced protein oxidation and lipid peroxidation. J Biochem Molecul Toxicol 2007, 21:110-117.
24. Alvarez JG, Storey BT: Taurine, hypotaurine, epinephrine and albumin inhibit lipid peroxidation in rabbit spermatozoa and protect against loss of motility. Biol Reprod 1983, 29:548-555.
25. Cetin F, Dincer S, Ay R, Guney S: Systemic taurine prevents brain from lipopolysaccharide-induced lipid peroxidation in rats. Afr J Pharm Pharmacol 2012, 6:1099-1105.
26. Deng Y, He N, Xu L, Li X, Li S, Li Z, Liu H: A rapid scavenger of lipid peroxidation product malondialdehyde: new perspective of taurine. Adv Sci Lett 2011, 4:442-448.
27. Hayakawa K, Kimura M, Kasaha K, Matsumoto K, Sansawa H, Yamori Y: Effect of a γ-aminobutyric acid-enriched dairy product on the blood pressure of apontaneously hypertensive and normotensive Wistar-Kyoto rats. Brit J Nutr 2004, 92:411-417.
28. Leventhal AG, Wang Y, Pu M, Zhou Y, Ma Y: GABA and its agonists improved visual cortical function in senescent monkeys. Science 2003, 300(5620):812-815.
29. Hua T, Kao C, Sun Q, Li X, Zhou Y: Decreased proportion of GABA neurons accompanies age-related degradation of neuronal function in cat striate cortex. Brain Res Bull 2008, 75:119-125.
30. Song H, Xu X, Wang H, Wang H, Tao Y: Exogenous γ-aminobutyric acid alleviates oxidative damage caused by aluminium and proton stresses n barley seedlings. J Sci Food Agric 2010, 90:1410-1416.
31. Sivakumar R, Babu PVA, Shyamaladevi CS: Asp and Glu prevents isoproterenol-induced cardiac toxicity by alleviating oxidative stress in rats. Exp Toxicol Pathol 2011, 63:137-142.
32. Kikugawa K, Beppu M: Involvement of lipid oxidative products in the formation of fluorescent and cross-linked proteins. Chem Phys Lipids 1987, 44:277-296.
33. Deng Y, Xu L, Zeng X, Li Z, Qin B, He N: New perspective of GABA as an inhibitor of formation of advanced lipoxidation end-products: it's interaction with malondiadehyde. J Biomed Nanotechnol 2010, 6:318-324.
34. Erdtmann-Vourliotis M, Riechert U, Maye P, Grecksch G, Hollt V: Pentylenetetrazole (PTZ)-induced c-fos expression in the hippocampus of kindled rats is suppressed by concomitant treatment with naloxone. Brain Res 1998, 792:299-308.
35. Fathollahi Y, Motamedi F, Semnanian S, Zardoshti M: Examination of persistent effects of repeated administration of pentylenetetrazol on rat hippocampal CA1: evidence from in vitro study on hippocampal slices. Brain Res 1997, 758:92-98.
36. Onorato JM, Jenkins AJ, Thorpe SR, Baynes JW: Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. J Biol Chem 2000, 275:21177-21184.
37. Fang C, Peng M, Li G, Tian J, Yin D: New functions of glucosamine as a scavenger of the lipid peroxidation product malondialdehyde. Chem Res Toxicol 2007, 20:947-953.
38. Zhang F, Mao Y, Qiao H, Jiang H, Zhao H, Chen X, Tong L, Sun X: Protective effects of taurine against endotoxin-induced acute liver injury after hepatic ischemia reperfusion. Amino acids 2010, 38:237-245.
39. Cai J, Chen J, He H, Yin Z, Zhu Z, Yin D: Carbonyl stress: malondialdehyde induces damage on rat hippocampal neurons by disturbance of Ca(2+) homeostasis. Cell Biol Toxicol 2009, 25:435-445.
40. Bernard C, Cossart R, Hirsch JC, Esclapez M, Ben-Ari Y: What is GABAergic inhibition? How is it modified in epilepsy? Epilepsia 2000, 41(Suppl 6):890-895.
41. Tian J, Dang HL, Kaufman D: Combining antigen-based therapy with GABA treatment synergistically prolongs survival of transplanted ß-cells in diabetic NOD mice. Plos One 2011, 6:e25337.
42. Li F, Yang Z, Lu Y, Wei Y, Wang J, Yin D, He R: Malondialdehyde suppresses cerebral function by breaking homeostasis between excitation and inhibition in turtle Trachemys scripta. Plos One 2010, 12:e15325.
43. Gilgun-Sherki Y, Melamed E, Offen D: Oxidative stress inducedneurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 2001, 40:959-975.
44. Gil P, Farinas F, Casado A, Lopez-Fernandez E: Malondialdehyde: a possible marker of ageing. Gerontology 2002, 48:209-214.
45. Leutner S, Eckert A, Muller WE: ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain. J Neural Transm 2001, 108:955-967.